HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.
Huang FX, Wu JW, Cheng XQ, Wang JH, Wen XZ, Li JJ, Zhang Q, Jiang H, Ding QY, Zhu XF, Zhang XS, Ding Y, Li DD.
Huang FX, et al. Among authors: jiang h.
Front Immunol. 2022 Aug 8;13:902167. doi: 10.3389/fimmu.2022.902167. eCollection 2022.
Front Immunol. 2022.
PMID: 36003385
Free PMC article.